1. The presence of two RNA-degrading enzymes, one with optimum activity at pH5-6 (acid ribonuclease) and the other with optimum activity at pH7-8 (alkaline ribonuclease), in rat adrenals has been demonstrated. The acid ribonuclease was localized in themitochondrialfractionwhereasthealkalineribonuclease was present in mitochondria as well as in the supernatant fraction. Freezing and thawing of mitochondria and treatment with Triton X-100 gave a three-to fourfold increase in acid-ribonuclease activity, whereas the mitochondrial alkalineribonuclease activity was practically unaffected. 2. The amount offree ribonuclease in the adrenal supernatant was small. Treatment of the supernatant fraction with N-ethylmaleimide resulted in release oflarge amounts ofribonuclease activity, indicating the presence of a ribonuclease inhibitor having reactive thiol groups. 3. Considerable amounts of free ribonuclease inhibitor in excess over the bound alkaline ribonuclease are present in the rat-adrenal supernatant fraction. The inhibitor is heat-labile and non-diffusible. A 400-500-fold purification of the ribonuclease inhibitor was achieved by ammonium sulphate fractionation, treatment with calcium phosphate gel and DEAE-cellulose chromatography. It is concluded that the adrenal inhibitor is protein in nature, similar to the inhibitor present in rat liver. Roth (1956a Roth ( , 1957 has reported the presence of an inhibitor for ribonuclease activity in rat-liver supernatant fraction. Shortman (1961) has demonstrated from purification studies of the rat-liver inhibitor that the inhibitor activity is associated with a fraction that is mostly protein. Eichel, Figueroa & Goldenberg (1961) have provided evidence for the presence of ribonuclease inhibitor in rat adipose tissue.
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There have been a number of attempts to assess the possible role of the ribonuclease inhibitor in RNA metabolism and protein synthesis by determining the changes in the concentrations of ribonuclease and ribonuclease inhibitor after altered physiological states in the organism. Thus the changes in inhibitor activity have been studied in rat liver after whole-body X-irradiation (Roth, 1956b) or during regeneration after partial hepatectomy (Shortman, 1962b) and in different cancerous tissues (Brody, 1957; Roth, 1962 of Schneider & Hogeboom (1945) . The homogenate was centrifuged at 500g in an International model PR-2 refrigerated centrifuge to remove nuclei and unbroken cells. Mitochondria were separated at 5000g for 15min. These were washed twice with 10vol. of 0-25M-sucrose and recentrifuged under the same conditions. The resulting mitochondrial pellet was suspended in 10vol. of 0-25M-sucrose for the assay of free ribonuclease activity. Total ribonuclease activity was determined after freezing and thawing a 1:10 suspension of mitochondria in water or after treatment with Triton X-100 (0.1%, v/v) at 40 for 20min.
The supernatant obtained after sedimenting mitochondria was spun in a Spinco model L ultracentrifuge at 105000g for 1 hr. and the resulting supernatant fraction was used in the studies on the ribonuclease inhibitor.
Determination of ribonuclease activity. Ribonuclease activity was determined as described by Brody (1957) , by following the release of acid-soluble nucleotides on incubation of 2-5mg. of dialysed yeast RNA with a 1:10 homogenate or equivalent cell fraction in a final volume of 3-Oml. Incubations at 370 were carried out in 20mM-tris-HCI buffer, pH7-8, for the determination of alkalineribonuclease activity and in 20mM-acetate buffer, pH5-6, for the assay of acid-ribonuclease activity. For the supernatant enzyme, preincubation of the supernatant fraction with N-ethylmaleimide (final concn. 3 mm) was carried out for 30min. before incubation with the substrate. The reaction was stopped by the addition of 3-Oml. of 10% (w/v) trichloroacetic acid containing uranyl acetate (0-5%), and the acid-soluble nucleotides were determined by measuring the extinction at 290mu in a Beckman model DU spectrophotometer, trichloroacetic acid giving negligible extinction at this wavelength. The amount of enzyme releasing acid-soluble nucleotides equivalent to 1 extinction unit under the above conditions is expressed as 1 ribonuclease unit.
Assay of ribonudea8e inhibitor. The system for the assay of ribonuclease inhibitor (Roth & Wojner, 1961 ) consisted of 0-2 ml. of supernatant fraction, 0-15 ml. of 50mM-EDTA, pH7-8, 0125/Lg. of crystalline pancreatic ribonuclease (Worthington Biochemical Corp., Freehold, N.J., U.S.A.), 1-Oml. of veronal-acetate buffer (50mM with respect to both sodium diethylbarbiturate and sodium acetate), pH7-8, and 1-Oml. of 1% RNA solution in a final volume of 3-Oml. Incubation was carried out for 30min. at 37°. The reaction was stopped by the addition of 3-0ml. of precipitating reagent [N-HC1 in 76% (v/v) ethanol containing LaC13,7H20 (0-5%)]. Release of acid-soluble nucleotides was estimated by the change in extinction at 260m,u. One unit of inhibitor is equivalent to the concentration causing 50% inhibition of 0-005,ug. of crystalline pancreatic ribonuclease.
Purification of ribonuclea8e inhibitor. Sheep adrenals contained inhibitor activity comparable with that from rat adrenals. The inhibitor from sheep adrenals resembled the rat-liver inhibitor in all its characteristics, being heat-labile, non-diffusible and containing active thiol groups.
A 30g. portion of sheep adrenals was homogenized in 3 vol. of 0-25M-sucrose and the supernatant fraction obtained by spinning the homogenate at 105000g was treated with solid (NH4)2SO4 to give 35% saturation. The precipitate was removed by centrifugation at 60000g in the Spinco model L ultracentrifuge for 20min. Then (NH4)2SO4 was added to the supernatant to give 55% saturation and the mixture was centrifuged at 60000g for 20min. The pellet was dissolved in 20ml. of cold water and this was treated with calcium phosphate gel, prepared according to the method of Swingle & Tiselius (1951) . The inhibitor was eluted from the gel with 20-25ml. of 0-2M-phosphate buffer, pH6-4. The eluate was diluted to give a phosphate concentration of 10mM and NaCl and EDTA were added to give concentrations of 0-1M and 1mM respectively. This solution was applied to DEAE-cellulose columns. The chromatography on DEAE-cellulose columns was essentially as described by Shortman (1961) . The column was washed with 50ml. of buffered saline [NaCl (0-15M), potassium phosphate buffer, pH6-4 (10mm), and EDTA (1mM)]. The elution was carried out with a linear gradient of 0-15-1-5M-NaCl in 10mM-phosphate buffer, pH6-4, containing EDTA (1mM). The eluate was collected in 5-Oml. fractions.
Determination of protein. Protein was determined by the method of Lowry, Rosebrough, Farr & Randall (1951) .
RESULTS AND DISCUSSION
Two apparently distinct enzymes from various tissues that hydrolyse RNA have been described by Roth (1954 ), Stevens & Reid (1956 , Maver & Greco (1956) alkaline ribonuclease (optimum pH7-8-8-2, heatstable and acid-stable) and the other acid ribonuclease (optimum pH 5-2-5-8, heat-labile and acidlabile). Fig. 1 illustrates the pH-activity curve of ribonuclease in adrenal homogenate. The curve reveals two peaks of activity, one at pH5-6 and another at pH 7-8. These results indicate that rat adrenals contain both acid and alkaline ribonucleases with pH optima similar to those reported for the ribonucleases of rat liver (Roth, 1957) . The distribution of acid and alkaline ribonucleases in the subcellular fractions of rat liver and adrenals is shown in Table 1 . The acid-ribonuclease activity is localized in the mitochondrial fraction, the activity in the supernatant fraction being negligible. Alkaline-ribonuclease activity is present in mitochondria as well as in the supernatant fraction. The ribonuclease activity in the supernatant fraction is low. But, on the addition of N-ethylmaleimide, a 3-4-fold increase in the activity is observed. The same extent of release of supernatant enzyme was obtained when p-chloromercuribenzoate was present in the incubation system at a final concentration of 0-4mm. These results are similar to those reported for rat liver (Roth, 1958) . Calculation of the distribution of alkaline-ribonuclease activity between mitochondria and supernatant shows that about 60% of the ribonuclease activity could be recovered in the supernatant fraction, after taking into account the ribonuclease activity released on treatment with N-ethylmaleimide, and about 20% in the mitochondria. Experiments showed that mitochondrial activity is not increased on treatment of mitochondria with N-ethylmaleimide. However, other treatments, such as freezing and thawing and treatment with detergents like Triton X-100, increase the mitochondrial ribonuclease activity. The increase is mainly in the acid-ribonuclease activity, alkaline-ribonuclease activity being unaffected by these treatments (Table 1 ).
These results demonstrate that, as in rat liver, a major part of the ribonuclease activity in the adrenals is present in a latent form, the supernatant enzyme occurring in combination with an inhibitor, which could be inactivated by thiolbinding reagents, and the mitochondrial acidribonuclease activity present presumably as a membrane component.
The significance of the intracellular location of acid and alkaline ribonucleases of mitochondria is not known, though attempts have been made to study the characteristics of the two enzymes (Stevens & Reid, 1956; Zytko et al. 1958; Maver & Greco, 1962) . Nodes, Reid & Whitcut (1962) , working with purified enzymes, found minor differences in their specificities towards synthetic substrates. However, one difference between acid and alkaline ribonucleases is that, whereas acid ribonuclease is not inhibited by the rat-liver inhibitor, all the three mammalian alkaline ribonucleases tested, namely those of rat-liver mitochondria and supernatant as well as the pancreatic enzyme, are all inhibited (Shortman, 1962a) .
Although mitochondrial alkaline-ribonuclease activity is present in a free form whereas the supernatant alkaline-ribonuclease activity is present along with the inhibitor presumably in combination, as inferable from observations with use of thiol-binding agents, it has been shown that purified alkaline ribonucleases of mitochondria and super- Table 1 . Di8tribution of ribonuclea8e activity in rat-adrenal fraction8 and comparison with liver cell fractions Free ribonuclease was determined by following the release of acid-soluble nucleotides on incubation of a 1:10 homogenate or equivalent cell fraction with 2-5mg. of dialysed yeast RNA. Total ribonuclease activity of mitochondria at pH5-6 or 7-8 was determined in the same manner after freezing and thawing a 1:10 suspension in water (*) or after treatment with 0-1% (v/v) Triton X-100 (t). The supernatant activity was assayed with and without preincubation with N-ethylmaleimide (final concn. 3mM). The activities are expressed as ribonuclease activity units/50 mg. of tissue or equivalent cell fraction. One unit ofribonuclease activity is the amount ofenzyme releasing acid-soluble nucleotides equivalent to 1 extinction unit under the above conditions. The results are averages of four independent determinations. Samples (4-0ml.) were added after 0, 10, 20, 30 and 40min. to 4-0ml. of precipitating reagent [N-HCI in 76% (v/v) ethanol containing LaCl3,7H20 (0.5%)]. The supernatant was diluted 1:50 and readings were taken at 260mu. The plots represent the averages of three independent experiments. Curve 1, activity of adrenal supernatant alone; curve 2, activity of supernatant fraction preincubated with N.ethylmaleimide; curve 3, activity of crystalline pancreatic ribonuclease; curve 4, activity of crystalline pancreatic ribonuclease in the presence of supernatant; curve 5, activity of crystalline pancreatic ribonuclease in the presence of supernatant and N-ethylmaleimide.
natant are identical in their specificity towards substrates (Nodes et al. 1962; Beard & Razzell, 1964) .
A time-course study of the action of N-ethylmaleimide on the adrenal supernatant fraction is shown in Fig. 2 . The ribonuclease activity in the supernatant fraction is low (curve 1). On the addition of N-ethylmaleimide, a threefold increase in activity is observable (curve 2), indicating a bound form of ribonuclease in the supernatant fraction, and that this is released on inactivation of the inhibitor by thiol-binding reagents like N-ethylmaleimide. However, the supernatant fraction is not saturated with respect to ribonuclease, since considerable amounts of crystalline enzyme may be inactivated by the addition of supernatant fraction (curves 3 and 4). This inhibition is overcome in the presence of N-ethylmaleimide (curve 5).
The results of two typical experiments to test the heat-sensitivity of the inhibitor are given in Table 2 . The inhibitor is relatively heat-sensitive, being completely destroyed after heating for 5min. at 650. Together with the fact that the inhibitor is non-diffusible in crude as well as in purified preparations, the observation suggests that it may be protein in nature.
The inhibitor activity could be purified several hundred-fold by employing methods used for the purification of proteins. An analysis of the results of a standard purification procedure is presented in Table 3 . Initial purification was carried out by combined ammonium sulphate precipitation and calcium phosphate gel treatment. The specific activity of the inhibitor preparation thereby increased 10-12-fold; the partially purified inhibitor was next passed through a column of DEAEcellulose. All of the inhibitor activity was retained on the column. Elution was carried out with a linear gradient of 0-15-1-5M-sodium chloride buffered at pH6-4 with tris. The highest inhibitor concentrations were obtained in fractions 13, 14, 15 and 16. These eluate fractions also contained most of the 280m,u-absorbing material. A 400-500-fold purification was thus attained.
Though an analysis of the purified inhibitor preparation has not been undertaken, previous studies also indicate that protein forms the major constituent in purified rat-liver inhibitor preparations. No other component was present to any considerable extent (Shortman, 1962a) .
The protein nature of the inhibitor (Shortman, 1961) , as well as its lability in vivo (Roth, 1956b; Shortman, 1962b; Girija et al. 1965) , lead one to speculate that the inhibitor may play an important role in the regulation of RNA metabolism, especially in view of recent reports implicating ribonuclease as the enzyme involved in the degradation of rapidly turned over RNA in bacterial (Artman & Engelberg, 1964) as well as in animal systems (Harris, 1963) .
